CA-XPRIZE
22.6.2021 18:26:04 CEST | Business Wire | Press release
XPRIZE , the global leader in designing and operating incentive competitions to solve humanity’s grand challenges, officially announced today the teams moving forward in the $10M XPRIZE Rainforest aimed at improving our understanding of the rainforest ecosystem.
Sponsored by Alana Foundation , the five-year XPRIZE Rainforest is a call-to-action to help save rainforests through the development of transformative, scalable, and affordable technology to autonomously survey and monitor biodiversity in real-time, leading to insights that communicate the health, well-being, and value of standing tropical rainforests. XPRIZE Rainforest is co-developing an inclusive framework throughout all stages of the competition that ensures competing teams co-design and co-create solutions with Indigenous Peoples and local communities as key stakeholders and not just beneficiaries.
These 33 teams will now leverage existing and emerging technologies, such as robotics, remote sensing, data analysis, artificial intelligence, and machine learning, to develop new rainforest biodiversity survey tools that deliver information more quickly and affordably, and in unprecedented detail.
“There has never been a more urgent time for our planet,” Peter Houlihan, Vice President of Biodiversity & Conservation at XPRIZE said. “These teams show great promise for developing exciting new approaches to enhance shared understandings of the planet’s most complex and biodiverse terrestrial ecosystems.”
All registered teams submitted a qualifying submission detailing their approach and proposed technologies. The judging panel selected 33 teams, which hail from more than 16 countries and bring a collection of diverse backgrounds and industry experience.
The XPRIZE Rainforest qualified teams are:
- ACT NOW - Amazonas Action Alliance, Ecuador
- AirWrx, Canada
- Alouatta, Mexico
- AraceEye, Canada
- BiodivExplorer, Switzerland
- BioSTREAM, United Kingdom
- Bioverse, Brazil
- Blue Devil Rainforest Divers, United States
- Brazilian Team, Brazil
- Dinizia Excelsa, Brazil
- FLOATING FAB, Peru
- GainForest, Switzerland
- Inspire Robotics, United States
- KAA Initiative, Brazil
- Kreativno pero, Serbia
- Lorax, United States
- Map of Life, United States
- Mimicry Maniacs, United States
- Mowgli, India
- Nga Kaitiaki o te Ngaherehere, New Zealand
- PROVIDENCE PLUS, Spain
- Rainforest Quest, United States
- Reforester, Netherlands
- Selvascope, Netherlands
- Short-Eared Dogs, United States
- Team Morpho, United States
- Team Robotics, Japan
- Team Waponi!, United States
- Tengo Research Foundation, Panama
- Treeswift (Trefos Inc), United States
- Welcome to the Jungle, United States
- XiniX AI, Belgium
- Zissou, Brazil
Additional details about all competing teams can be found here . Additionally, watch Peter Houlihan speak about XPRIZE Rainforest, performanced-based design and goal setting for impact on a World Rainforest Day event as part of the Rainforest Ambitions series. Register here .
In order to win the competition, the winning team will survey the most biodiversity contained in 100 hectares of tropical rainforest in 24 hours and produce the most impactful real time insights within 48 hours.
“Nature Based Solutions are key to confronting the climate crises. We are celebrating teams from the Americas, Europe, Oceania, and Asia all united on the same goal: protecting our standing forests that provide water, biodiversity, livelihood, and our prosperity with an inclusive bioeconomy. The joining of these teams shows the urgency we have to change the scenario we are living. The world needs intelligent, possible, powerful solutions, but above all, made by people in communion. We hope that Alana Rainforest XPRIZE will inspire activism, science, and innovation for the benefit of the environment and people all over the world,” said Ana Lúcia Villela, president of Alana Foundation.
Successful technologies developed in the competition will demonstrate scalable and affordable capabilities that measurably improve biodiversity monitoring, including through better autonomous operations, innovative detection methodologies, and rapid data integration to provide new Insights in real time and at unprecedented levels of detail.
The XPRIZE Rainforest Judging Panel consists of an experienced and talented group of experts working at the highest levels of academia, leading conservation organizations, prestigious research institutions and grantmaking organizations. The 9 judges include:
- Dr. Jorge Ahumada –– Senior Wildlife Conservation Scientist, Conservation International
- Dr. Luisa Arnedo –– Primatologist, Conservationist, and Senior Program Officer, National Geographic Society
- Dr. Stuart Davies –– Director, Center for Tropical Forest Science-Forest Global Earth Observatory at the Smithsonian Institution
- Dr. Lian Pin Koh –– Professor of Conservation, Science, Technology & Policy, Founder, Conservation Drones
- Dr. Lucia Lohmann –– Executive Director, Association for Tropical Biology and Conservation
- Dr. Kevin Njabo –– Associate Director & Africa Director, UCLA Center for Tropical Research and the Congo Basin Institute
- Dr. Vojtech Novotny –– Head, Dep. of Ecology, Biology Centre, Czech Academy of Sciences Director, New Guinea Binatang Research Center, Professor of Ecology, Zoology Dep., University of South Bohemia
- Atossa Soltani –– Founder & President of the Board, Amazon Watch; Director of Global Strategy for Amazon Sacred Headwaters Initiative
- Dr. Dave Thau –– Lead Scientist, World Wildlife Fund Global Data and Tech
The next step for the competition is the semifinal round and then a final round of testing before the grand prize decision in 2024. A total prize purse of $10 Million US dollars (USD) will be awarded throughout the lifespan of the prize, including a $250,0000 Bonus Prize that may be awarded at the Judging Panel’s discretion to one or more Finalist Teams whose Solutions demonstrate groundbreaking achievements. Milestone prizes will also be awarded equally for up to 25 teams that advance to Semifinals and up to 10 teams that advance to finals testing.
ABOUT XPRIZE
XPRIZE, a 501(c)(3) nonprofit organization, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the $100M XPRIZE Carbon Removal, $15M XPRIZE Feed the Next Billion, $10 Million ANA Avatar XPRIZE and $5 Million XPRIZE Rapid Reskilling. For more information, visit xprize.org.
ABOUT ALANA FOUNDATION
Alana Foundation is an independent philanthropic organisation founded in 2012 in the United States. The Foundation supports initiatives in the areas of environment, inclusive education and health science research through grants and co-funding partnerships. It also engages with networks and global movements in those areas.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210622005926/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development17.2.2026 15:10:00 CET | Press release
Caidya, a leading global, mid-sized CRO focused on accelerating clinical development for innovative biopharmaceutical companies, today announced the appointment of Michael Clay as chief operating officer (COO). Clay will lead Caidya’s global operational delivery, client engagement model, and execution strategy, further strengthening the company’s ability to serve innovative biopharma sponsors across the U.S., Europe, and Asia-Pacific. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217431202/en/ Michael Clay, Caidya's Chief Operating Officer Clay brings a distinguished track record in global project delivery and site relationship strategy. He has led large-scale global programs across 60+ countries and built high-performing delivery organizations known for operational rigor and sponsor trust. Notably, Clay has extensive leadership experience across Asia-Pacific, where speed, regulatory nuance, and close site collaboration
Gurobi Appoints Dr. Pascal Van Hentenryck to Lead AI Innovation Lab17.2.2026 15:00:00 CET | Press release
Renowned optimization and AI technologies leader to advance hybrid approaches for demanding decision challenges. Gurobi Optimization, LLC, the leader in decision intelligence technology, is pleased to announce that Dr. Pascal Van Hentenryck has joined the company as head of the Gurobi AI Innovation Lab (GAIL). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217170385/en/ Dr. Pascal Van Hentenryck, Head of AI Innovation Lab, Gurobi Optimization As part of Gurobi’s long-term product and technology strategy, the Gurobi AI Innovation Lab is a focused Research & Development initiative dedicated to advancing the combination of multiple AI technologies with optimization to solve complex, large-scale, and time-critical decision problems. “Pascal brings exceptional leadership across mathematical optimization and complementary AI technologies,” said Dr. Oliver Bastert, CTO, Gurobi Optimization. “While mathematical optimization remai
Esri and Pix4D Launch Real-Time Terrestrial Mapping Workflow17.2.2026 14:00:00 CET | Press release
Alliance Brings Seamless Integration of Asset Data into ArcGIS for PIX4Dcatch Users Pix4D joins with Esri to launch new terrestrial scanning workflow for infrastructure-focused organizations. Esri and Pix4D workflow lets field teams capture accurate 3D models and augmented reality using PIX4Dcatch app data integrated directly into ArcGIS Online in real time. New integration enables users to document subsurface assets with seamless precision. Workflow brings high-fidelity, georeferenced documentation and instant verification to the project lifecycle for improved accuracy. Explore the PIX4Dcatch app and publish 3D data to ArcGIS Online. Esri, the global leader in geographic information system (GIS) technology, has launched a terrestrial mapping workflow with Pix4D. A Switzerland-based photogrammetry software company, Pix4D specializes in mobile reality capture and site-digitization. The combined workflow allows field teams to capture and process asset data and manage it within ArcGIS, Es
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample17.2.2026 14:00:00 CET | Press release
Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, for certain foundational CRISPR-Cas9 intellectual property for use in NGS library preparation. While CRISPR-Cas9 technologies are most commonly associated with their unique ability to find and cut for genome editing, Watchmaker is leveraging it in a fundamentally different way: as a programmable, stoichiometric binding tool to address one of the most persistent and under-optimized steps in NGS workflows – library normalization. “Normalization has quietly become a bottleneck as sequencing throughput has scaled,” said Brian Kudlow, CSO and Founderat Watchmaker Genomics. “This license gives us the freedom to rethink normalization from first principles, using CRISPR-Cas9 in a way that’s orthogonal to editing but highly aligned with modern sequenc
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression17.2.2026 12:30:00 CET | Press release
Two highly statistically significant positive Phase 3 trials confirm highly differentiated profile for COMP360, demonstrating a level of clinical effect that has historically been extremely difficult to achieve in TRDCOMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect, with a generally well-tolerated and safe profileIn COMP006, two doses of COMP360 25 mg versus 1 mg demonstrated a highly statistically significant and clinically meaningful reduction in symptom severity as measured by MADRS2 with a mean difference of -3.8 comparing 25 mg to 1 mg (p<0.001)3Clinically meaningful reduction in MADRS (≥ 25%) observed in significant number of participants in 25mg arm of both trials with 25% in COMP005 and 39% in COMP006Statistically significant rapid onset from the day following administration maintained at all measured timepoints through Week 6 in both clinical trials in the 25 mg armIn COMP005, participa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
